Curonest Pharmaceuticals Private Limited

Curonest Pharmaceuticals Private Limited - trading in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U51909KA2020PTC133817 Incorporated 18 April 2020 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2024
₹38.1 Lakh
▼ 16% YoY
Net profit · FY 2024
₹80,353
Net margin 2.1%
EBITDA · FY 2024
₹1.65 Lakh
EBITDA margin 4.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Curonest Pharmaceuticals Private Limited

Data last updated:

Curonest Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 18 April 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2020PTC133817.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rishi Ranjan and Manoranjan Kumar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2024, the company reported a revenue of ₹38.1 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹80,353 (net margin 2.1%) and EBITDA of ₹1.65 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.

Curonest Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-20-0000572).

Company details

CIN U51909KA2020PTC133817
Registration Number 133817
Incorporation Date 18 April 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-JH-20-0000572

Recognitions & Rankings of Curonest Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-JH-20-0000572

Contact details

Curonest Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.

  • Registered Address
    F – 301 N.D. Oliva #29/2A&29/3 Begur Hobli Haralakunte Village Somsunderpalaya Hs, R Layout 1, Bangalore, Karnataka, India – 560037
  • Industry
    Trading, Specialty, Wholesale
Comprehensive company report
Curonest Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Curonest Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Curonest Pharmaceuticals Private Limited, buy the company report.

Financials of Curonest Pharmaceuticals Private Limited

FY 2024 filings available

Curonest Pharmaceuticals Private Limited reported revenue of ₹38.1 Lakh (down 16% YoY) for FY 2024.

Revenue · FY 2024
₹38.1 Lakh ▼ 16%
Net profit · FY 2024
₹80,353 margin 2.1%
EBITDA · FY 2024
₹1.65 Lakh margin 4.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▲ 29%

Revenue fell 16% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.65 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹80,353
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.3%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Curonest Pharmaceuticals Private Limited, buy the company report.

Board of directors of Curonest Pharmaceuticals Private Limited

Curonest Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rishi RanjanDirector18 Apr 20206 Years 6 MonthsCurrent
Manoranjan KumarDirector18 Apr 20206 Years 6 MonthsCurrent

Peer comparison

Curonest Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Bashu Pharmaceuticals Private Limited₹38.26 Lakh (FY 2025)28.0%Patna, Bihar, India
Emrick Pharmaceuticals Private Limited₹38.25 Lakh (FY 2025)-18.0%Bulandshahr, Uttar Pradesh, India
Arvensis Pharmaceuticals Private Limited₹38.11 Lakh (FY 2024)-24.0%Raipur, Chhattisgarh, India
Curonest Pharmaceuticals Private Limitedthis company₹38.1 Lakh (FY 2024)₹80,3532.1%-16.0%Bangalore, Karnataka, India
Katharine Pharmaceuticals Private Limited₹38.1 Lakh (FY 2025)45.0%Jaipur, Rajasthan, India
Pentaproud Pharmaceuticals Private Limited₹37.93 Lakh (FY 2025)-23.0%Kochi, Kerala, India
Futurewell Pharmaceuticals Private Limited₹37.89 Lakh (FY 2024)Kolkata, West Bengal, India
Himcure Pharmaceuticals Private Limited₹37.86 Lakh (FY 2024)22.0%Rampur, Uttar Pradesh, India

To see the full peer comparison of Curonest Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Curonest Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Curonest Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Curonest Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Manoranjan Kumar was appointed as Director on 18 Apr 2020.

AGM
Curonest Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Curonest Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Appointed
Manoranjan Kumar was appointed as Director.
Appointed
Rishi Ranjan was appointed as Director.
Incorporation
18 Apr 2020
Curonest Pharmaceuticals Private Limited was registered on 18 Apr 2020 with Roc Bangalore & aged 6 years 6 months as per MCA records.

Frequently asked questions

Curonest Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 18 April 2020 (6+ years old) and is registered under CIN U51909KA2020PTC133817.

Curonest Pharmaceuticals has 2 current directors:

The latest financial statements of Curonest Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Curonest Pharmaceuticals is U51909KA2020PTC133817. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Curonest Pharmaceuticals was incorporated on 18 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.

The peers of Curonest Pharmaceuticals by revenue are Bashu Pharmaceuticals Private Limited, Emrick Pharmaceuticals Private Limited, Arvensis Pharmaceuticals Private Limited, Katharine Pharmaceuticals Private Limited, Pentaproud Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Manoranjan Kumar was appointed as Director on 18 Apr 2020. Rishi Ranjan was appointed as Director on 18 Apr 2020.

Yes, Curonest Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-20-0000572).

The registered office of Curonest Pharmaceuticals is at F – 301 N.D. Oliva #292A&293 Begur Hobli Haralakunte Village Somsunderpalaya Hs, R Layout 1, Bangalore, Karnataka, India – 560037.

Curonest Pharmaceuticals operates in the trading industry, in the specialty segment.

Curonest Pharmaceuticals can be reached at its registered office: F – 301 N.D. Oliva #292A&293 Begur Hobli Haralakunte Village Somsunderpalaya Hs, R Layout 1, Bangalore, Karnataka, India – 560037.